Logo

American Heart Association

  36
  0


Final ID:

Anticoagulation in the cancer patient with AF: how to best balance risks?

  • Fradley, Michael  ( University of Pennsylvania , Bryn Mawr , Pennsylvania , United States )
  • Asad, Zain Ul Abideen  ( OU Health , Edmond , Oklahoma , United States )
  • Author Disclosures:
    Michael Fradley: DO have relevant financial relationships ; Research Funding (PI or named investigator):Medtronic:Past (completed) ; Consultant:Zoll:Past (completed) ; Consultant:Novartis:Expected (by end of conference) ; Consultant:Abbvie:Past (completed) ; Consultant:Pfizer:Past (completed) ; Consultant:Janssen:Past (completed) ; Consultant:AstraZeneca:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now) | Zain Ul Abideen Asad: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Managing Arrhythmias in Special Populations

Friday, 11/07/2025 , 02:15PM - 03:30PM

Cardiovascular Seminar

More abstracts on this topic:
More abstracts from these authors:
Trends in Atrial Fibrillation Related Mortality in Coronary Artery Disease Patients Aged 65 and Older in the United States: Insights from the CDC WONDER Database

Naveed Muhammad Abdullah, Asad Zain Ul Abideen, Balla Sudarshan, Munir Bilal, Ali Ahila, Iqbal Rabia, Azeem Bazil, Omer Rehan Muhammad, Akbar Usman, Sattar Yasar, Gonuguntla Karthik, Khan Muhammad

Trends in Atrial Fibrillation Related Mortality in Metabolic Syndrome Patients Aged 65 and Older in the United States: Insights from the CDC WONDER Database

Naveed Muhammad Abdullah, Asad Zain Ul Abideen, Balla Sudarshan, Munir Bilal, Azeem Bazil, Omer Rehan Muhammad, Ali Ahila, Iqbal Rabia, Akbar Usman, Khan Muhammad, Gonuguntla Karthik, Sattar Yasar

You have to be authorized to contact abstract author. Please, Login
Not Available